These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 23567485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R, Löbmann K, Grohganz H, Strachan C, Rades T.
    Mol Pharm; 2014 Jul 07; 11(7):2381-9. PubMed ID: 24852326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R, Saarinen J, Strachan CJ, Korhonen O, Laitinen R.
    Eur J Pharm Biopharm; 2018 Nov 07; 132():112-126. PubMed ID: 30248394
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin.
    Ojarinta R, Heikkinen AT, Sievänen E, Laitinen R.
    Eur J Pharm Biopharm; 2017 Mar 07; 112():85-95. PubMed ID: 27888143
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of a screening method for co-amorphous formulations of drugs and amino acids.
    Kasten G, Grohganz H, Rades T, Löbmann K.
    Eur J Pharm Sci; 2016 Dec 01; 95():28-35. PubMed ID: 27531419
    [Abstract] [Full Text] [Related]

  • 15. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients.
    Hussain A, Smith G, Khan KA, Bukhari NI, Pedge NI, Ermolina I.
    Eur J Pharm Sci; 2018 Oct 15; 123():395-403. PubMed ID: 30076953
    [Abstract] [Full Text] [Related]

  • 16. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T.
    Mol Pharm; 2011 Oct 03; 8(5):1919-28. PubMed ID: 21815614
    [Abstract] [Full Text] [Related]

  • 17. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L, Tale S, Reineke TM.
    Mol Pharm; 2015 Jul 06; 12(7):2537-43. PubMed ID: 26046484
    [Abstract] [Full Text] [Related]

  • 18. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
    Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T.
    J Pharm Sci; 2005 Sep 06; 94(9):1998-2012. PubMed ID: 16052554
    [Abstract] [Full Text] [Related]

  • 19. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
    Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Nov 01; 81(1):96-109. PubMed ID: 20674291
    [Abstract] [Full Text] [Related]

  • 20. [The development of co-amorphous drug systems].
    Yao J, Shi NQ, Wang XL.
    Yao Xue Xue Bao; 2013 May 01; 48(5):648-54. PubMed ID: 23888685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.